Service profile
Rezolute
Biopharmaceutical company developing plasma kallikrein inhibitor therapies for congenital hyperinsulinism and other metabolic diseases, with clinical programs targeting rare pediatric endocrine disorders.
About
What Rezolute is
Biopharmaceutical company developing plasma kallikrein inhibitor therapies for congenital hyperinsulinism and other metabolic diseases, with clinical programs targeting rare pediatric endocrine disorders.
losclouds keeps public details for this profile. There are no catalog offerings to compare yet.
EnterpriseHealthcare
At a glance
| Fact | Value |
|---|---|
| Official site | https://rezolute.com |
| Status coverage | Public status page |
| Founded | 2010 |
| Headquarters | Redwood City, California, United States |
| Categories | Enterprise, Healthcare |
Loading offerings...